JAK2 and ovarian cancer: PEAK1 has currently been confirmed to promote cell proliferation and migration, inhibit cell apoptosis, and play a tumor‐promoting role through ERK1/1 and JAK2 pathways in breast cancer, colorectal cancer, and lung cancer.35, 36, 37 However, relevant functions in ovarian cancer have not been reported.